Amanote Research
Register
Sign In
Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors
Metabolites
- Switzerland
doi 10.3390/metabo7030048
Full Text
Open PDF
Abstract
Available in
full text
Categories
Biochemistry
Endocrinology
Metabolism
Molecular Biology
Diabetes
Date
September 16, 2017
Authors
Unknown
Publisher
MDPI AG
Related search
Pyruvate Dehydrogenase Kinase 1 and Carbonic Anhydrase IX Targeting in Hypoxic Tumors
Neoplasma
Cancer Research
Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors
Molecular Pharmaceutics
Drug Discovery
Molecular Medicine
Pharmaceutical Science
Carbonic Anhydrase IX in Adult and Pediatric Brain Tumors
Discovery of 4Hydroxy-3-(3-(Phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IX
Extracellular Carbonic Anhydrase Activity and Carbonic Anhydrase Inhibitors in the Circulatory System of Fish
Physiological Zoology
Carbonic Anhydrase Inhibition and Cytotoxicity Studies of Mannich Base Derivatives of Thymol
Journal of Enzyme Inhibition and Medicinal Chemistry
Medicine
Drug Discovery
Pharmacology
Carbonic Anhydrase Inhibition by Acetazolamide Reduces in Vitro Epileptiform Synchronization
Neuropharmacology
Molecular Neuroscience
Cellular
Pharmacology
Carbonic Anhydrase of Spinach: Studies on Its Location, Inhibition, and Physiological Function
Plant Physiology
Plant Science
Genetics
Physiology
Carbonic Anhydrase Inhibition With a Series of Novel Benzenesulfonamide-Triazole Conjugates
Journal of Enzyme Inhibition and Medicinal Chemistry
Medicine
Drug Discovery
Pharmacology
